MegaBlog- – this is an amalgamation of posts from popular trading blogs . This section will allow you to track interesting topics and track popular trends in trading., understand what traders live.
Arrow Electronics (NYSE: ARW) - supplier and reseller in the field of high technologies. The business of the company is favored by the market environment. But low margins and geopolitical tensions could hurt reporting.
Today we have a very speculative idea: take stock of the cloud service Workiva (NYSE: WK) to capitalize on the growth of his business. Growth potential and validity: 20% behind 14 Months; 10% per year for 10 years. Why stocks can go up: because this is the cloud sector, everything grows there.
Every day of the company, that are traded on the stock market, disclose information about the business: publish financial statements, hold press conferences, present new products and approve dividends. We have collected all the important events of the coming week for those, who invests in securities.
Rusagro (MCX: AGRO) — the largest diversified agro-industrial holding in Russia. The company operates the fourth largest farmland. 26 April Rusagro published operating results for the first quarter of 2021.
According to the China Passenger Car Association, car maker Tesla (NASDAQ: TSLA) sold in April 25 845 Chinese-made electric cars 27% less, than in March. Of them 14 174 have been exported to other countries. Association informs, that sales of electric vehicles in the country as a whole decreased by 12%.
Today we have an extremely speculative idea.: take shares of the cloud fintech service Blackline (NASDAQ: BL), in order to capitalize on the rebound of stocks after the fall. Growth potential and validity: 20% behind 14 Months, 44% behind 5 years. Why stocks can go up: because they fell well. How do we act: we take shares on 102,31 $. Without guarantees Our reflections are based on the analysis of the company's business and the personal experience of our investors, but remember: not a fact, that the investment idea will work like this, as we expect. Everything, what we write, are forecasts and hypotheses, not a call to action. To rely on our reflections or not – it's up to you. If you want to be the first to know, did the investment work?, subscribe: as soon as it becomes known, we will inform. And what is there with the forecasts of the author of the Study, like this and this, talk about, that the accuracy of target price predictions is low. And that's ok: there are always too many surprises on the stock exchange and accurate forecasts are rarely realized. If the situation were reversed, then funds based on computer algorithms would show results better than people, but alas, they work worse. So we're not trying to build complex models.. The profitability forecast in the article is the author's expectations. We specify this forecast for the landmark: as with the investment idea as a whole, readers decide for themselves, it is worth trusting the author and focusing on the forecast or not. На чем компания зарабатывает Это ПО для бухгалтеров компаний, allowing to automate and optimize the accounting process. To understand, how it works, можно заглянуть в отчет компании или посмотреть ее разъясняющие видео. Like many similar businesses, the company's revenue is divided into two complementary segments. Подписка и техподдержка — 93%. …
Investidea: Blackline, because money doesn't sleep Read more
Today we have a very speculative idea: take stock of fintech software manufacturer Bill.com (NYSE: BILL), to capitalize on the growth of his business. Growth potential and validity: 20% behind 16 Months, 10% per annum during 15 years. Why stocks can go up: quotes fell, and the sector is promising.
Chinese holding Alibaba Group (NYSE: BABA) 13 May reported for the fourth quarter and fiscal year 2021. The company's annual revenue increased by 41% — up to 717.3 billion yuan. Excluding Consolidation Sun Art, Chinese hypermarket chain, sales have increased 32%.
Realizing the futility of treating depressive conditions with traditional drugs using the example of their loved ones, George Goldsmith, Ekaterina Malievskaya and Lars Wild founded Compass Pathways (CP). Synthetic psychedelic psilocybin was chosen as an innovative treatment for depression, found in hallucinogenic mushrooms, - in combination with psychological support. The new drug was named COMP360, and in 2018 US FDA (FDA) approved clinical trials of the drug on volunteers. What's going on here Readers have long asked us to start examining the financial statements and business fundamentals of American issuers. Suggest in the company's comments, analysis of which you would like to read. There are many screenshots with tables from reports in the overview. To make it easier to use them, we translated them into Google tables and translated them into Russian. note: there are several sheets. And keep in mind, that companies round up some numbers in their reports, therefore, the totals in graphs and tables may not converge. Download the table from the report In 2019, CP completed the first phase of drug trials on the group, formed from 89 volunteers. Tests showed good results in almost all subjects, reducing the primary symptoms of the disease within six months after taking the drug. In 2020, a second group of 216 volunteers was formed for the second phase of testing. The second phase of clinical trials is aimed at finding the optimal dosage of COMP360 for various forms of depressive disorder and in combination with the support of a psychotherapist. The company plans to publish the results of the second phase of research in the fourth quarter of 2021. Сравнение рынков и перспективы Производители каннабиса заинтересованы в производстве марихуаны и не занимаются психическим здоровьем своих будущих потребителей. Nevertheless, the hype around this topic artificially warmed up the market, а котировки акций производителей легальной марихуаны …
Обзор Compass Pathways: mushrooms, research and mental health Read more